Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06581822
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
None
First Post:
2024-05-29
Brief Title:
Biomarkers for Pharmacoresponse in Bipolar Disorder - Coagulation
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Biomarkers for Pharmacoresponse in Bipolar Disorder - Coagulation
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Previous studies indicate an association between severe psychiatric disorders such as bipolar disorder and increased risk of venous thromboembolism However to which extent this association is influenced by lithium treatment is currently unknown In this prospective cohort study the investigators aim to investigate the effect of bipolar disorder and lithium treatment on coagulation and the counterpart fibrinolysis
Detailed Description:
The investigators will analyse differences in coagulation
using a case-control design where cases are bipolar patients not yet treated with lithium and controls are healthy volunteers Swedish ethical review authority Dnr 2023-05799-02 PI Kristoffer Månsson KI
using a prospective cohort design following the patients over time
using a case-control design where cases are bipolar patients not yet treated with lithium and controls are healthy volunteers Swedish ethical review authority Dnr 2023-05799-02 PI Kristoffer Månsson KI
using a prospective cohort design following the patients over time
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None